Eupraxia Pharmaceuticals is trading at $7.94, up 15.4%, with the healthcare-sector rally providing the clearest available context—not a confirmed company-specific catalyst.
- Shares compare with the November 3 close of $6.88.
- No confirmed company-specific announcement explains the November 4 pre-market move; Nasdaq showed no updates available.
- Healthcare stocks rallied after Democrats won control of both chambers of Congress, and health names were among pre-market gainers.